4596 — Kubota Pharmaceutical Holdings Co Cashflow Statement
0.000.00%
- ¥3bn
- ¥1bn
- ¥27m
Annual cashflow statement for Kubota Pharmaceutical Holdings Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2,437 | -2,616 | -2,016 | -1,490 | -1,333 |
Depreciation | |||||
Non-Cash Items | 14.3 | 84.8 | 19.2 | 149 | 143 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 129 | -41.2 | -149 | -82.9 | -71 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2,249 | -2,514 | -2,087 | -1,336 | -1,195 |
Capital Expenditures | -13.4 | -8.67 | -58 | -66.3 | -49.7 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 354 | 3,571 | 563 | 21.3 | 6.68 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 340 | 3,563 | 505 | -45 | -43.1 |
Financing Cash Flow Items | 4.59 | — | 3.1 | — | 1.12 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 454 | 171 | 1,447 | 96.6 | -88.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,659 | 1,444 | 71.7 | -1,281 | -1,313 |